Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleDonor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
- Where
- Houston
- People
- 16
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03425526 - Phase 1Taking peoplePhase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
- Where
- Houston
- Age
- 12 years and over
- People
- 25
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04991870 - Phase 1Taking peopleTrivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
- Where
- Houston
- Age
- 12 months to 25 years
- People
- 38
- Run by
- Baylor College of Medicine
See details and how to joinNCT05010564 - Phase 1/2Taking peopleA Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Where
- Ann Arbor, Atlanta, Baltimore, Charlotte, Chicago, Cincinnati, Dallas, Denver, Indianapolis, Kansas City, Los Angeles, Memphis, Miami, New York, Philadelphia, Phoenix, Portland, Salt Lake City, San Francisco, Seattle, Washington D.C.
- Age
- 1 month to 21 years
- People
- 58
- Run by
- Therapeutic Advances in Childhood Leukemia Consortium
See details and how to joinNCT05849662 - No phaseTaking peopleBrain Slice Explants to Predict Drug Response in Brain Tumors
- Where
- Chapel Hill
- People
- 50
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT05978557 - Phase 1Taking peopleA Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Where
- Houston
- Age
- 2 years to 18 years
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06191978 - Phase 3Taking peopleXylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
- Where
- Albany, Albuquerque, Ann Arbor, Atlanta, Austin, Birmingham, Charlottesville, Chicago, Cleveland, Corpus Christi, Dallas, Danville, Denver, Des Moines, Fargo, Fort Myers, Grand Rapids, Green Bay, Jacksonville, Kalamazoo, Knoxville, Lexington, Little Rock, Louisville, Madera, Madison, Nashville, Norfolk, Oakland, Orlando, Pensacola, Philadelphia, Pittsburgh, Scarborough, Spokane, The Bronx, Toledo, Wilmington
- Age
- 1 year to 25 years
- People
- 556
- Run by
- Children's Oncology Group
See details and how to joinNCT07022678 - No phaseNot yet taking people in United StatesSymptom Trajectory Approaches to Research
- Where
- Columbus, Los Angeles, Madison, New York, Portland
- Age
- 8 years to 18 years
- People
- 228
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT07804875 - No phaseTaking peopleClinical Orthopaedic Data Bank (Acute and Chronic)
- Where
- Gainesville
- People
- 10,000
- Run by
- University of Florida
See details and how to joinNCT00411060 - No phaseTaking peopleInternational Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
- Where
- Chicago
- People
- 1,000
- Run by
- Ilya Khaytin
See details and how to joinNCT03088020 - No phaseTaking peopleNeurocognition in Congenital Central Hypoventilation Syndrome (CCHS)
- Where
- Chicago, Los Angeles, Philadelphia, Seattle
- Age
- 3 years to 85 years
- People
- 1,000
- Run by
- Ilya Khaytin
See details and how to joinNCT03568669 - Phase 1/2Taking peopleStudy of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Where
- Birmingham, Boston, Chapel Hill, Dallas, Duarte, Goodyear, Greenville, Houston, Jacksonville, Lake Success, Morristown, Newnan, New Orleans, New York, Phoenix, Rochester, Scottsdale, Tampa, Zion
- Age
- 12 years and over
- People
- 160 worldwide
- Run by
- Sellas Life Sciences Group
See details and how to joinNCT04588922 - No phaseTaking peopleOvarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
- Where
- Chicago
- Age
- Up to 11 years
- People
- 250
- Run by
- Erin Rowell
See details and how to joinNCT05299710 - No phaseTaking peopleOvarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
- Where
- Chicago
- Age
- Up to 30 years
- People
- 250
- Run by
- Erin Rowell
See details and how to joinNCT05309746 - Phase 1Taking peopleCabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
- Where
- Aurora, Philadelphia, San Francisco
- Age
- 5 years to 40 years
- People
- 30
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT06156410 - Phase 1Taking peopleA Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
- Where
- Houston
- Age
- 2 years to 21 years
- People
- 22
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06397027 - Phase 1/2Taking peopleEflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Where
- Birmingham, Dallas, Gainesville, Hackensack, Hartford, Hershey, Honolulu, Kansas City, Little Rock, Miami, Nashville, Orlando, St Louis, Tampa
- Age
- Up to 26 years
- People
- 265
- Run by
- Milton S. Hershey Medical Center
See details and how to joinNCT06465199 - Phase 2Taking peopleTipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Where
- Austin, Dallas, Durham, Hartford, Hershey, Honolulu, Little Rock, Miami, Nashville, Orlando, Portland, St Louis
- Age
- 1 year to 21 years
- People
- 98
- Run by
- Giselle Sholler
See details and how to joinNCT06540963 - No phaseTaking peopleCulturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial
- Where
- Memphis
- Age
- 10 years to 17 years
- People
- 116
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07160621 - Phase 1Taking peopleB7-H3.CD28Z.CART in Solid Tumors
- Where
- Boston
- Age
- 9 months to 30 years
- People
- 40
- Run by
- Robbie Majzner
See details and how to joinNCT07358260 - Phase 1Taking peopleB7-H3.CD28Z.CART in CNS Neoplasms
- Where
- Boston
- Age
- 2 years to 21 years
- People
- 70
- Run by
- Robbie Majzner
See details and how to joinNCT07390539 - No phaseTaking peopleFeasibility of Incorporating a Standardized Substance Use Measure With Linked-Brief Intervention Into Routine Psychosocial Care of Adult Childhood Cancer Survivors
- Where
- Memphis
- Age
- 15 years and over
- People
- 30
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07516301 - No phaseTaking peopleToxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
- Where
- Bethesda, Portsmouth
- Age
- 4 years and over
- People
- 300
- Run by
- Henry M. Jackson Foundation for the Advancement of Military Medicine
See details and how to joinNCT07652580 - Phase 1/2Taking peopleDomatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Where
- Columbus, St Louis, Tampa, The Bronx
- Age
- 12 years to 40 years
- People
- 74
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT07725380 - No phaseTaking peopleCancer Clinical Trials Financial Reimbursement Program
- Where
- Dallas
- People
- 1,200
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT05402033